Active Surveillance With Selective Radical Treatment for Localized Prostate Cancer
- 1 September 2007
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in The Cancer Journal
- Vol. 13 (5), 289-294
- https://doi.org/10.1097/ppo.0b013e318156ff65
Abstract
The challenge of managing localized prostate cancer is to distinguish patients with clinically relevant cancers, who may benefit from radical treatment, from the remainder who do not need any intervention. Active surveillance with selective radial intervention is a management strategy that offers patients the hope of avoiding "unnecessary" treatment without detriment to their long-term survival. Here we discuss the rationale for active surveillance, and the early results. There is no consensus on the optimum active surveillance protocol, with uncertainty regarding the interpretation of PSA kinetics, repeat biopsy results and prostate imaging. In the future, it is likely that molecular markers will revolutionize our ability to select patients who will benefit from definitive treatment. In the meantime, active surveillance provides an attractive way of reducing over treatment.Keywords
This publication has 31 references indexed in Scilit:
- A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survivalBritish Journal of Cancer, 2006
- Radical Prostatectomy versus Watchful Waiting in Early Prostate CancerNew England Journal of Medicine, 2005
- A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate CancerJNCI Journal of the National Cancer Institute, 2003
- Quality of Life after Radical Prostatectomy or Watchful WaitingNew England Journal of Medicine, 2002
- A Randomized Trial Comparing Radical Prostatectomy with Watchful Waiting in Early Prostate CancerNew England Journal of Medicine, 2002
- Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy.Journal of Clinical Oncology, 1998
- Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate CancerJAMA, 1998
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1998
- Sex or survival: trade-offs between quality and quantity of life.Journal of Clinical Oncology, 1991